# Congenital Chylothorax and Congenital Pulmonary Airway Malformation: Case Report and Literature Review

**Authors:** Andréa L. Corso, Amanda M. Magdaleno, Carolina R. Cappellaro, Mateus M. Neves, Geórgia P. F. Oliveira, Iara R. S. Lucena, José C. Fraga

PMC · DOI: 10.1002/rcr2.70223 · 2025-06-16

## TL;DR

This case report discusses the rare co-occurrence of congenital chylothorax and congenital pulmonary airway malformation in a newborn and the challenges in managing these conditions.

## Contribution

The paper presents a novel case of concurrent congenital chylothorax and CPAM and proposes a treatment strategy when conservative measures fail.

## Key findings

- Thoracic duct ligation and abrasive pleurodesis were performed during CPAM resection but failed to resolve the chylothorax.
- Chemical pleurodesis with povidone-iodine was ultimately successful in resolving the chylothorax after 56 days.
- The paper suggests that chemical pleurodesis is a viable option when conservative and surgical interventions fail.

## Abstract

The association of two rare but important congenital conditions—congenital chylothorax (CCT) and congenital pulmonary airway malformation (CPAM)—can be challenging to manage, especially in the absence of well‐established protocols. We report an association between CPAM and CCT in a newborn. After birth, CCT did not respond to conservative treatment, and at the time of CPAM resection, thoracic duct ligation and abrasive pleurodesis were also performed. Despite these interventions, the CCT persisted even with the subsequent administration of octreotide and propranolol. Finally, after 56 days, chemical pleurodesis with povidone‐iodine was performed. Chest tube drainage ceased, and the thoracic drain was removed 4 days later. Conservative treatment remains the first‐line approach for neonatal CCT. However, when CCT is associated with CPAM and fails to respond to conservative measures, thoracic duct ligation should be considered at the time of lung malformation resection. If these interventions remain ineffective, chemical pleurodesis is a viable therapeutic option.

The association of two rare but important congenital conditions—congenital chylothorax (CCT) and congenital pulmonary airway malformation (CPAM)—can be challenging to manage, especially in the absence of well‐established protocols. We report our experience and management of an association between CPAM and CCT in a newborn.

## Linked entities

- **Chemicals:** povidone-iodine (PubChem CID 410087), octreotide (PubChem CID 448601), propranolol (PubChem CID 4946)
- **Diseases:** congenital chylothorax (MONDO:0011331), congenital pulmonary airway malformation (MONDO:0016580)

## Full-text entities

- **Diseases:** Congenital Chylothorax (MESH:C535461), CPAM (MESH:D056151), CCT (MESH:D002916), lung malformation (MESH:D008171)
- **Chemicals:** propranolol (MESH:D011433), octreotide (MESH:D015282)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12168237/full.md

---
Source: https://tomesphere.com/paper/PMC12168237